From Casetext: Smarter Legal Research

Littlejohn v. Janssen Research & Dev., LLC

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION
Apr 13, 2015
Case No. 4:15CV194 CDP (E.D. Mo. Apr. 13, 2015)

Opinion

Case No. 4:15CV194 CDP

04-13-2015

KIEONNA LITTLEJOHN, et al., Plaintiffs, v. JANSSEN RESEARCH & DEVELOPMENT, LLC, et al., Defendants.


MEMORANDUM AND ORDER

This matter is before the Court on a motion to stay by several defendants, as well as the plaintiffs' motion to immediately remand. Pursuant to 28 U.S.C. § 636(b), the motions were referred to United States Magistrate Judge Nannette A. Baker. Judge Baker filed a Report and Recommendation, in which she recommended that the motion to stay be denied and the motion to remand be granted. She advised the parties that they had fourteen days to file written objections to her recommendations. See Section 636(b)(1)(C).

The moving defendants filed timely objections. The plaintiffs also filed a memorandum alerting the Court that one plaintiff's citizenship had been misstated in the Report and Recommendation.

I have reviewed de novo all matters relevant to the motions, and I conclude that the defendants' objections have no merit. Although plaintiff Kieonna Littlejohn is a citizen of Illinois who has alleged she first suffered injury in Missouri, rather than a citizen of Missouri as the Report and Recommendation states, substituting her actual alleged citizenship does not change the fact that there is no complete diversity among the parties. As such, I agree with Judge Baker that this court lacks subject-matter jurisdiction over this action.

(See Pet., Doc. 15, p. 3.)

Contrary to the defendants' objections, Judge Baker properly determined that in an action with multiple potential jurisdictional deficiencies, this Court has discretion over which jurisdictional issue to resolve first. See, e.g., Ruhrgas AG v. Marathon Oil Co., 526 U.S. 574, 585 (1999). Furthermore, this Court has discretion to remand an action for lack of federal jurisdiction despite the existence of a conditional transfer order to pending multidistrict litigation. See Rule 2.1(d), Rules of Procedure of the United States Judicial Panel on Multidistrict Litigation.

Finally, even assuming the Eighth Circuit Court of Appeals had explicitly recognized fraudulent misjoinder as an exception to the complete-diversity requirement and that a lack of personal jurisdiction over a nondiverse defendant supported the theory that parties had been fraudulently misjoined, personal jurisdiction over the nondiverse defendants is not so improbable here to demonstrate that the parties have been "egregiously" misjoined. In re Prempro Prods. Liab. Litig., 591 F.3d 613, 622 (8th Cir. 2010).

Accordingly,

IT IS HEREBY ORDERED that the Report and Recommendation of the United States Magistrate Judge [#23] is SUSTAINED, ADOPTED, and INCORPORATED herein.

IT IS FURTHER ORDERED that the defendants' motion to stay [#13] is denied, and the plaintiffs' motion to immediately remand or shorten the briefing schedule [#18] is granted.

IT IS FINALLY ORDERED that this case is remanded to the Circuit Court of the City of St. Louis, State of Missouri, from which it was removed.

/s/_________

CATHERINE D. PERRY

UNITED STATES DISTRICT JUDGE
Dated this 13th day of April, 2015.


Summaries of

Littlejohn v. Janssen Research & Dev., LLC

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION
Apr 13, 2015
Case No. 4:15CV194 CDP (E.D. Mo. Apr. 13, 2015)
Case details for

Littlejohn v. Janssen Research & Dev., LLC

Case Details

Full title:KIEONNA LITTLEJOHN, et al., Plaintiffs, v. JANSSEN RESEARCH & DEVELOPMENT…

Court:UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MISSOURI EASTERN DIVISION

Date published: Apr 13, 2015

Citations

Case No. 4:15CV194 CDP (E.D. Mo. Apr. 13, 2015)

Citing Cases

T.R. v. Janssen Pharms., Inc.

(E.D. Mo. Jan. 4, 2017); Spann v. Boehringer Ingelheim Pharm., Inc., No. 4:16-CV-902 (RLW), 2016 WL 7243535…

Edmondson v. Pfizer, Inc.

.D. Mo. Jan. 4, 2017); Spann v. Boehringer Ingelheim Pharm., Inc., No. 4:16-CV-902 (RLW), 2016 WL 7243535…